Viridian Therapeutics (formerly miRagen Therapeutics)

United States
Waltham, Massachusetts, United States, 02453

Company profile

Viridian Therapeutics (formerly miRagen Therapeutics) company profile

Viridian Therapeutics provides treatments for patients with diseases that are underserved by therapies. They develops product candidates to treat patients who suffer from thyroid eye disease, a debilitating orphan disease, and early-stage programs focused on targets and indications.

Business identity

Contact email
[email protected]
Phone number
+1 617 272 4600
Operating status
Active
Company type
For Profit
Employee range
101-250 employees
Revenue range
$10M-$100M
Founded
2007-01-01, Year

Headquarters

Postal code
02453
Country code
US
Continent
North America

Capital profile

Funding and company signals

Funding stage
IPO
Funding rounds
16
Total equity funding
$1.1B
Last funding
Post IPO Equity / $289M / 2025-10-21
Last equity funding
Post IPO Equity / $289M
Investors
13
Lead investors
7
Founders
2
Articles
140
Exited on
2021-09-23

Founders and investors

Founders

Eric Newell OlsonWilliam Marshall

Lead investors

Atlas VentureBoulder VenturesDRI HealthcareHercules CapitalJAFCOMRL Ventures FundRemeditex Ventures

Investors

Atlas VentureBoulder VenturesFidelityHercules CapitalMRL Ventures Fund